Kelvin S Ng
Kelvin S Ng
Harvard-MIT Division of Health Sciences & Technology
Verified email at
Cited by
Cited by
Engineering cells with intracellular agent–loaded microparticles to control cell phenotype
JA Ankrum, OR Miranda, KS Ng, D Sarkar, C Xu, JM Karp
Nature protocols 9 (2), 233-245, 2014
Generating iPSCs: Translating Cell Reprogramming Science into Scalable and Robust Biomanufacturing Strategies
M Silva, L Daheron, H Hurley, K Bure, R Barker, AJ Carr, D Williams, ...
Cell stem cell 16 (1), 13-17, 2015
Emerging medical devices for minimally invasive cell therapy
ED O'Cearbhaill, KS Ng, JM Karp
Mayo Clinic Proceedings 89 (2), 259-273, 2014
Triggered drug release from dynamic microspheres via a protein conformational change
WJ King, NJ Pytel, K Ng, WL Murphy
Macromolecular bioscience 10 (6), 580-584, 2010
Tetrandrine identified in a small molecule screen to activate mesenchymal stem cells for enhanced immunomodulation
Z Yang, J Concannon, KS Ng, K Seyb, LJ Mortensen, S Ranganath, F Gu, ...
Scientific Reports 6, 30263, 2016
Beyond hit-and-run: stem cells leave a lasting memory
KS Ng, TM Kuncewicz, JM Karp
Cell metabolism 22 (4), 541-543, 2015
Extracellular Vesicles Commercial Potential As Byproducts of Cell Manufacturing for Research and Therapeutic Use
JA Smith, KS Ng, BE Mead, S Dopson, B Reeve, J Edwards, MJA Wood, ...
BioProcess International, 0
The system can't perform the operation now. Try again later.
Articles 1–7